Imagine the freedom of fewer IBS-D Symptoms
Reach for new possibilities with the Enviva study. The study is exploring the effects of an investigational drug on symptoms of IBS-D.
Irritable Bowel Syndrome with Predominant Diarrhea
Researchers are studying how the investigational drug may help ease discomfort from symptoms such as moderate to severe abdominal pain, bloating, and unpleasant stool consistency.
Study information:
Condition: Irritable Bowel Syndrome with Diarrhea (IBS-D)
Location: Las Vegas, Nevada
Duration: Approximately 19 weeks
Participation: Up to 8 visits
Compensation: Up to $700
Eligibility:
18 years of age or older
Recurrent abdominal pain and/or bloating
Frequent loose or watery stools (i.e., diarrhea prominent IBS)
Willing to complete a daily diary of symptoms on a mobile app
Other study requirements apply.
Participants may receive:
Compensation up to $700
Study-related healthcare, exams, and testing at no cost
Study support and monitoring by a healthcare team
Access to new potential treatment options
Some participants may receive placebo
Get started today.
You are not committed to participate in a study by completing this form. Participation is voluntary, and you may leave at any time if you change your mind.
What is IBS-D?
Prevalence of IBS in the United States
Irritable Bowel Syndrome is a collection of symptoms that appear together without the presence of damage or disease to the digestive tract. Individuals with IBS experience abdominal pain and changes to their bowel movements that include diarrhea, constipation, or both.
It is estimated that about 12% of the US population suffers from IBS. Factors that increase the likelihood of developing IBS include a family history of IBS, a history of stressful life events, and severe infection of the digestive tract.
The subtype of IBS known as Irritable Bowel Syndrome with Persistent Diarrhea (IBS-D) is defined by abnormal bowel movement where more than a quarter of stools are loose and watery.
Current therapy options include prescription medications, stress management, and dietary supplements. Enviva is researching an investigational drug that works differently than currently approved medications and has potential to help relieve unpleasant symptoms.
Information provided by: www.envivastudy.com
